Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk factors for osteoporosis in Crohn's disease: infliximab, corticosteroids, body mass index, and age of onset.

Inflammatory bowel diseases - 1 May 2013

Azzopardi Neville, Ellul Pierre

Abstract excerpt

BACKGROUND: We analyzed the characteristics associated with increased risk of osteoporosis in patients with Crohn's disease in Malta. METHOD: Eighty-three patients with histologically and endoscopically confirmed Crohn's disease underwent a DEXA bone density scan and their phenotypic characteristics were analyzed. RESULTS: There was a significant association between body mass index and bone mineral density (P =...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Absorptiometry, Photon
Share to Adrenal Cortex Hormones
Share to Anti-Inflammatory Agents, Non-Steroidal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibodies, Monoclonal

Share to Bone Density

Share to Crohn Disease

Share to Infliximab

Share to Osteoporosis

Source

Identifiers

PMID: 23511037
DOI: 10.1097/MIB.0b013e31828075a7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk factors for osteoporosis in Crohn's disease: infliximab, corticosteroids, body mass index, and age of onset.PMID 23511037Read ↗

Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease.Semantic proximity Read ↗

Osteoporosis in Celiac Disease: An UpdateSemantic proximity Read ↗

ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn’s DiseaseSemantic proximity Read ↗

Extraintestinal complications of inflammatory bowel disease.Semantic proximity Read ↗

Age-of-onset-dependent influence of NOD2 gene variants on disease behaviour and treatment in Crohn's disease.Semantic proximity Read ↗

Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.Semantic proximity Read ↗

Bone loss in Crohn's disease: exercise as a potential countermeasure.Semantic proximity Read ↗

Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease.Semantic proximity Read ↗

Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease.Semantic proximity Read ↗

Allelic variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases.Semantic proximity Read ↗

The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.Semantic proximity Read ↗

IL-6, IL-1β, and TNF-α only in combination influence the osteoporotic phenotype in Crohn's patients via bone formation and bone resorption.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.